European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®

VIENNA, Va.–(BUSINESS WIRE)—- $CVM #Multikine–European Medicines Agency grants CEL-SCI a waiver of strict pediatric requirements, clearing the path towards marketing authorization for Multikine.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks